Point of Care Lipid Test Market by Product Type, Application, End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in obesity in populace
3.4.1.2. Increase in government initiatives to promote healthy lifestyle
3.4.1.3. Increase in prevalence of cardiovascular disease and diabetes
3.4.2. Restraints
3.4.2.1. High cost of product development
3.4.3. Opportunities
3.4.3.1. Growth potential of emerging economies
3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2. Devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. Consumables
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country

CHAPTER 5: POINT OF CARE LIPID TEST MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2. Endogenous Hyperlipemia
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. Combined hyperlipidemia
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4. Familial Hypercholesterolemia
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5. Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country

CHAPTER 6: POINT OF CARE LIPID TEST MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2. Hospitals and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3. Diagnostic Laboratories
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4. Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country

CHAPTER 7: POINT OF CARE LIPID TEST MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product Type
7.2.5.1.3 Market size and forecast, by Application
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product Type
7.2.5.2.3 Market size and forecast, by Application
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product Type
7.2.5.3.3 Market size and forecast, by Application
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product Type
7.3.5.1.3 Market size and forecast, by Application
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product Type
7.3.5.2.3 Market size and forecast, by Application
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product Type
7.3.5.3.3 Market size and forecast, by Application
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product Type
7.3.5.4.3 Market size and forecast, by Application
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product Type
7.3.5.5.3 Market size and forecast, by Application
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product Type
7.3.5.6.3 Market size and forecast, by Application
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product Type
7.4.5.1.3 Market size and forecast, by Application
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product Type
7.4.5.2.3 Market size and forecast, by Application
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product Type
7.4.5.3.3 Market size and forecast, by Application
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product Type
7.4.5.4.3 Market size and forecast, by Application
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product Type
7.4.5.5.3 Market size and forecast, by Application
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product Type
7.4.5.6.3 Market size and forecast, by Application
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product Type
7.5.5.1.3 Market size and forecast, by Application
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product Type
7.5.5.2.3 Market size and forecast, by Application
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product Type
7.5.5.3.3 Market size and forecast, by Application
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product Type
7.5.5.4.3 Market size and forecast, by Application
7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Company overview
9.1.2 Key Executives
9.1.3 Company snapshot
9.1.4 Operating business segments
9.1.5 Product portfolio
9.1.6 Business performance
9.1.7 Key strategic moves and developments
9.2 Callegari
9.2.1 Company overview
9.2.2 Key Executives
9.2.3 Company snapshot
9.2.4 Operating business segments
9.2.5 Product portfolio
9.2.6 Business performance
9.2.7 Key strategic moves and developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Company overview
9.3.2 Key Executives
9.3.3 Company snapshot
9.3.4 Operating business segments
9.3.5 Product portfolio
9.3.6 Business performance
9.3.7 Key strategic moves and developments
9.4 Menarini Group
9.4.1 Company overview
9.4.2 Key Executives
9.4.3 Company snapshot
9.4.4 Operating business segments
9.4.5 Product portfolio
9.4.6 Business performance
9.4.7 Key strategic moves and developments
9.5 Mico Bio Med
9.5.1 Company overview
9.5.2 Key Executives
9.5.3 Company snapshot
9.5.4 Operating business segments
9.5.5 Product portfolio
9.5.6 Business performance
9.5.7 Key strategic moves and developments
9.6 Nova Biomedical Corporation
9.6.1 Company overview
9.6.2 Key Executives
9.6.3 Company snapshot
9.6.4 Operating business segments
9.6.5 Product portfolio
9.6.6 Business performance
9.6.7 Key strategic moves and developments
9.7 SD Biosensor, Inc.
9.7.1 Company overview
9.7.2 Key Executives
9.7.3 Company snapshot
9.7.4 Operating business segments
9.7.5 Product portfolio
9.7.6 Business performance
9.7.7 Key strategic moves and developments
9.8 Sinocare Inc.
9.8.1 Company overview
9.8.2 Key Executives
9.8.3 Company snapshot
9.8.4 Operating business segments
9.8.5 Product portfolio
9.8.6 Business performance
9.8.7 Key strategic moves and developments
9.9 VivaChek Biotech (Hangzhou) Co.,Ltd
9.9.1 Company overview
9.9.2 Key Executives
9.9.3 Company snapshot
9.9.4 Operating business segments
9.9.5 Product portfolio
9.9.6 Business performance
9.9.7 Key strategic moves and developments
9.10 Zoetis Inc.
9.10.1 Company overview
9.10.2 Key Executives
9.10.3 Company snapshot
9.10.4 Operating business segments
9.10.5 Product portfolio
9.10.6 Business performance
9.10.7 Key strategic moves and developments

List of Tables
Table 1. Global Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 2. Point of Care Lipid Test Market for Devices, by Region, 2021-2031 (Revenue, $Million)
Table 3. Point of Care Lipid Test Market for Consumables, by Region, 2021-2031 (Revenue, $Million)
Table 4. Global Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 5. Point of Care Lipid Test Market for Endogenous Hyperlipemia, by Region, 2021-2031 (Revenue, $Million)
Table 6. Point of Care Lipid Test Market for Combined Hyperlipidemia, by Region, 2021-2031 (Revenue, $Million)
Table 7. Point of Care Lipid Test Market for Familial Hypercholesterolemia, by Region, 2021-2031 (Revenue, $Million)
Table 8. Point of Care Lipid Test Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 9. Global Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 10. Point of Care Lipid Test Market for Hospitals and Clinics, by Region, 2021-2031 (Revenue, $Million)
Table 11. Point of Care Lipid Test Market for Diagnostic Laboratories, by Region, 2021-2031 (Revenue, $Million)
Table 12. Point of Care Lipid Test Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 13. Point of Care Lipid Test Market, by Region, 2021-2031 (Revenue, $Million)
Table 14. North America Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 15. North America Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 16. North America Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 17. North America Point of Care Lipid Test Market, by Country, 2021-2031 (Revenue, $Million)
Table 18. U.S. Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 19. U.S. Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 20. U.S. Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 21. Canada Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 22. Canada Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 23. Canada Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 24. Mexico Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 25. Mexico Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 26. Mexico Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 27. Europe Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 28. Europe Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 29. Europe Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 30. Europe Point of Care Lipid Test Market, by Country, 2021-2031 (Revenue, $Million)
Table 31. Germany Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 32. Germany Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 33. Germany Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 34. France Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 35. France Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 36. France Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 37. UK Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 38. UK Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 39. UK Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 40. Italy Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 41. Italy Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 42. Italy Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 43. Spain Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 44. Spain Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 45. Spain Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 46. Rest of Europe Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 47. Rest of Europe Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 48. Rest of Europe Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 49. Asia-Pacific Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 50. Asia-Pacific Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 51. Asia-Pacific Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 52. Asia-Pacific Point of Care Lipid Test Market, by Country, 2021-2031 (Revenue, $Million)
Table 53. Japan Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 54. Japan Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 55. Japan Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 56. China Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 57. China Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 58. China Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 59. India Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 60. India Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 61. India Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 62. Australia Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 63. Australia Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 64. Australia Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 65. South Korea Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 66. South Korea Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 67. South Korea Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 68. Rest of Asia-Pacific Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 69. Rest of Asia-Pacific Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 70. Rest of Asia-Pacific Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 71. LAMEA Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 72. LAMEA Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 73. LAMEA Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 74. LAMEA Point of Care Lipid Test Market, by Country, 2021-2031 (Revenue, $Million)
Table 75. Brazil Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 76. Brazil Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 77. Brazil Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 78. Saudi Arabia Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 79. Saudi Arabia Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 80. Saudi Arabia Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 81. South Africa Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 82. South Africa Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 83. South Africa Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 84. Rest of LAMEA Point of Care Lipid Test Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 85. Rest of LAMEA Point of Care Lipid Test Market, by Application, 2021-2031 (Revenue, $Million)
Table 86. Rest of LAMEA Point of Care Lipid Test Market, by End-user, 2021-2031 (Revenue, $Million)
Table 87. Abbott Laboratories: Key Executives
Table 88. Abbott Laboratories: Company Snapshot
Table 89. Abbott Laboratories: Operating Segments
Table 90. Abbott Laboratories: Product Portfolio
Table 91. Abbott Laboratories: Net Sales
Table 92. Abbott Laboratories: Key Stratergies
Table 93. Callegari: Key Executives
Table 94. Callegari: Company Snapshot
Table 95. Callegari: Operating Segments
Table 96. Callegari: Product Portfolio
Table 97. Callegari: Net Sales
Table 98. Callegari: Key Stratergies
Table 99. F. Hoffmann-La Roche Ltd.: Key Executives
Table 100. F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 101. F. Hoffmann-La Roche Ltd.: Operating Segments
Table 102. F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 103. F. Hoffmann-La Roche Ltd.: Net Sales
Table 104. F. Hoffmann-La Roche Ltd.: Key Stratergies
Table 105. Menarini Group: Key Executives
Table 106. Menarini Group: Company Snapshot
Table 107. Menarini Group: Operating Segments
Table 108. Menarini Group: Product Portfolio
Table 109. Menarini Group: Net Sales
Table 110. Menarini Group: Key Stratergies
Table 111. Mico Bio Med: Key Executives
Table 112. Mico Bio Med: Company Snapshot
Table 113. Mico Bio Med: Operating Segments
Table 114. Mico Bio Med: Product Portfolio
Table 115. Mico Bio Med: Net Sales
Table 116. Mico Bio Med: Key Stratergies
Table 117. Nova Biomedical Corporation: Key Executives
Table 118. Nova Biomedical Corporation: Company Snapshot
Table 119. Nova Biomedical Corporation: Operating Segments
Table 120. Nova Biomedical Corporation: Product Portfolio
Table 121. Nova Biomedical Corporation: Net Sales
Table 122. Nova Biomedical Corporation: Key Stratergies
Table 123. Sd Biosensor, Inc.: Key Executives
Table 124. Sd Biosensor, Inc.: Company Snapshot
Table 125. Sd Biosensor, Inc.: Operating Segments
Table 126. Sd Biosensor, Inc.: Product Portfolio
Table 127. Sd Biosensor, Inc.: Net Sales
Table 128. Sd Biosensor, Inc.: Key Stratergies
Table 129. Sinocare Inc.: Key Executives
Table 130. Sinocare Inc.: Company Snapshot
Table 131. Sinocare Inc.: Operating Segments
Table 132. Sinocare Inc.: Product Portfolio
Table 133. Sinocare Inc.: Net Sales
Table 134. Sinocare Inc.: Key Stratergies
Table 135. Vivachek Biotech (Hangzhou) Co.Ltd : Key Executives
Table 136. Vivachek Biotech (Hangzhou) Co.Ltd : Company Snapshot
Table 137. Vivachek Biotech (Hangzhou) Co.Ltd : Operating Segments
Table 138. Vivachek Biotech (Hangzhou) Co.Ltd : Product Portfolio
Table 139. Vivachek Biotech (Hangzhou) Co.Ltd : Net Sales
Table 140. Vivachek Biotech (Hangzhou) Co.Ltd : Key Stratergies
Table 141. Zoetis Inc.: Key Executives
Table 142. Zoetis Inc.: Company Snapshot
Table 143. Zoetis Inc.: Operating Segments
Table 144. Zoetis Inc.: Product Portfolio
Table 145. Zoetis Inc.: Net Sales
Table 146. Zoetis Inc.: Key Stratergies

List of Figures
Figure 1. Segmentation of Point of Care Lipid Test Market, 2021-2031
Figure 2. Point of Care Lipid Test Market, 2021-2031
Figure 3. Top Investment Pockets, by Region
Figure 4. Porter Five-1
Figure 5. Porter Five-2
Figure 6. Porter Five-3
Figure 7. Porter Five-4
Figure 8. Porter Five-5
Figure 9. Point of Care Lipid Test Market: Drivers, Restraints and Opportunities
Figure 10. Point of Care Lipid Test Market, by Product Type, 2021 (%)
Figure 11. Comparative Share Analysis of Devices Point of Care Lipid Test Market, 2021 and 2031 (%)
Figure 12. Comparative Share Analysis of Consumables Point of Care Lipid Test Market, 2021 and 2031 (%)
Figure 13. Point of Care Lipid Test Market, by Application, 2021 (%)
Figure 14. Comparative Share Analysis of Endogenous Hyperlipemia Point of Care Lipid Test Market, 2021 and 2031 (%)
Figure 15. Comparative Share Analysis of Combined Hyperlipidemia Point of Care Lipid Test Market, 2021 and 2031 (%)
Figure 16. Comparative Share Analysis of Familial Hypercholesterolemia Point of Care Lipid Test Market, 2021 and 2031 (%)
Figure 17. Comparative Share Analysis of Others Point of Care Lipid Test Market, 2021 and 2031 (%)
Figure 18. Point of Care Lipid Test Market, by End-user, 2021 (%)
Figure 19. Comparative Share Analysis of Hospitals and Clinics Point of Care Lipid Test Market, 2021 and 2031 (%)
Figure 20. Comparative Share Analysis of Diagnostic Laboratories Point of Care Lipid Test Market, 2021 and 2031 (%)
Figure 21. Comparative Share Analysis of Others Point of Care Lipid Test Market, 2021 and 2031 (%)
Figure 22. Point of Care Lipid Test Market by Region, 2021
Figure 23. U.S. Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 24. Canada Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 25. Mexico Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 26. Germany Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 27. France Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 28. UK Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 29. Italy Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 30. Spain Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 31. Rest of Europe Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 32. Japan Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 33. China Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 34. India Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 35. Australia Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 36. South Korea Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 37. Rest of Asia-Pacific Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 38. Brazil Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 39. Saudi Arabia Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 40. South Africa Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 41. Rest of LAMEA Point of Care Lipid Test Market, 2021-2031 ($Million)
Figure 42. Top Winning Strategies, by Year
Figure 43. Top Winning Strategies, by Development
Figure 44. Top Winning Strategies, by Company
Figure 45. Product Mapping of Top 10 Players
Figure 46. Competitive Dashboard
Figure 47. Competitive Heatmap of Top 10 Key Players
Figure 48. Top Player Positioning, 2021
Figure 49. Abbott Laboratories.: Net Sales ($Million)
Figure 50. Callegari.: Net Sales ($Million)
Figure 51. F. Hoffmann-La Roche Ltd..: Net Sales ($Million)
Figure 52. Menarini Group.: Net Sales ($Million)
Figure 53. Mico Bio Med.: Net Sales ($Million)
Figure 54. Nova Biomedical Corporation.: Net Sales ($Million)
Figure 55. Sd Biosensor, Inc..: Net Sales ($Million)
Figure 56. Sinocare Inc..: Net Sales ($Million)
Figure 57. Vivachek Biotech (Hangzhou) Co.Ltd .: Net Sales ($Million)
Figure 58. Zoetis Inc..: Net Sales ($Million)

Executive Summary

According to the report titled, “Point of Care lipid Test Market," The point of care lipid test market was valued at $284.86 million in 2021, and is estimated to reach $426.6 million by 2031, growing at a CAGR of 4.1% from 2022 to 2031.

The Point of care lipid test market is likely to experience a significant growth rate of 4.1% from 2022-2031 owing to increasing market demand for point of care lipid test products from diagnostics and biotech s sector.

Point of care (POC) tests are clinical studies performed to identify persistent issues within a patient's body. The point-of-care diagnostics assists in delivering real-time results in a matter of minutes. These tests shorten one's stay in the clinic and assist in quickly analyzing inside problems. Thus, the point-of-care diagnostics give medical practitioners enough time to study the syndrome and give patients the right kind of clinical assistance. Moreover, Point-of-care lipid testing, which is used to measure cholesterol, low thickness lipoprotein, high thickness lipoprotein, and fatty oils, can be used to estimate blood lipid levels.

Major factors driving the growth of the point of care lipid test market include increase in obesity in populace. For instance, according to the World Health Organization (WHO), in 2019, an estimated 38.2 million children under the age of 5 years were overweight or obese. Once considered a high-income country problem, overweight and obesity are now on the rise in low- and middle-income countries, particularly in urban settings. In addition, increase in the prevalence of cardiovascular disease and rise in adoption of early diagnosis drive the growth of the market. For instance, according to mortality rate of heart diseases in urban and rural China 2020, by gender in 2020, the mortality rate of heart diseases among male residents in rural China stood at 174.87 deaths per 100,000 population, whereas the figure was 159.09 deaths per 100,000 population in urban China. Thus, increasing number of cases of cardiovascular is resulting in growing demand for its diagnosis, which is subsequently driving the growth of the market. Furthermore, key players in the market are focusing on adopting strategies to increase accessibility and utilization of point of care lipid test products in developing economies.

Moreover, increase in demand for technological advancements that improve speed, accuracy, and user-friendliness, as well as increasing market penetration rates of technologies such as self-testing handheld devices further propel the market growth. The market also offers growth opportunities to the key players in the market. As the increase in emerging economies, there is an estimated a rise in demand for the point of care lipid test products during the forecast period.

The global point of care lipid test market is segmented on the basis of product type, application, end user and region. As per product type, the market is categorized into devices and consumables. On the basis of application, it is bifurcated into endogenous hyperlipidemia, combined hyperlipidemia, familial hypercholesterolemia and others. On the basis of end user, it is segmented into hospitals and clinics, diagnostic laboratories and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

The key players profiled in the study includes the Abbott Laboratories, Callegari, F. Hoffmann-La Roche Ltd., Menarini Group, Mico Bio Med, Nova Biomedical Corporation, SD biosensor, inc., Sinocare Inc., VivaChek Biotech (Hangzhou) Co., Ltd, Zoetis Inc. The players in the market have been actively engaged in the adoption strategies such as product development, market expansion and agreement to remain competitive and gain advantage over the competitors in the market. For instance, In May 2020, Nova Biomedical announced the addition of C-reactive protein (CRP) testing to its Allegro capillary blood analyzer for point-of-care (POC) testing in primary care settings. The Allegro and its StatStrip companion meter provides 11 clinically important tests to help physicians make therapeutic decisions and adjustments during the patient visit. The Allegro analyzer and this new CRP test are available in CE regulated countries. Allegro will be submitted to the U.S. FDA for CLIA waived use.

Key Market Insights (Updated)

• By product type, the consumable segment was the highest revenue contributor to the market with a CAGR of 4.5% during the forecast period and is estimated to reach $301.38 million by 2031.
• Based on application, the endogenous hyperlipidemia segment was the highest revenue contributor to the market in 2021.
• Based on end user, the diagnostic laboratories segment was the highest revenue contributor to the market in 2021.
• Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 5.4% during the forecast period

Companies Mentioned

• Abbott Laboratories
• Callegari
• F. Hoffmann-La Roche Ltd.
• Menarini Group
• Mico Bio Med
• Nova Biomedical Corporation
• SD Biosensor, Inc.
• Sinocare Inc.
• VivaChek Biotech (Hangzhou) Co.,Ltd
• Zoetis Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.